ClareGeordie
2021-11-10

Here is what Baron Funds has to say about Moderna, Inc. in its Q3 2021 investor letter:
"Moderna, Inc. is a leader in the emerging field of mRNA-based vaccines and therapeutics. Shares performed well for the quarter. Moderna has been one of the most successful companies in the race to develop and provide a COVID-19 vaccine and is focusing on introducing a COVID-19 booster combined with the flu shot. With the COVID-19 vaccine success under its belt, we think Moderna has potential to disrupt the entire biopharmaceutical industry, from infectious disease vaccines to oncology and rare disease treatment."

Though now we are affacted by PFIZER pills in treating COVID19, we can still see it in oncology and rare disease treatment!

$Moderna, Inc.(MRNA)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法